Genedata Launches Genedata Screener® 4.0

Date Posted: Wednesday, January 11, 2006

Print Email to a friend

Genedata has announced the release of Genedata Screener® 4.0, an open and scalable solution for high throughout screening analysis.

Genedata claims that, the software boasts a well documented public application programming interface (API) and advanced procedures for analyzing high content screening data. 

"We've created a powerful and straightforward strategy for validating data quality and pinpointing the most promising lead compounds," says Dr. Michael Lindemann, Business Head Genedata Screener.

The software is designed to handle high content screening data and consolidates Screener's strengths in compound potency measurement using dose-response curve fitting.

The features include an API to link Screener’s database resources with the client’s existing corporate information portals.

The release has sorting and filtering capabilities that have been developed for lead discovery and compound validation.  

"Screener 4.0 addresses recent moves in HTS towards cellular systems, biomolecular aspects of ADMET, and functional genomics," explained Dr. Stephan Heyse, Project Head Genedata Screener.

Genedata has recently issued a joint statement with Evotec Technologies describing a high throughput solution for imaging screens. These features have been integrated into the 4.0 release. 

Dr. Lindemann added, "Our technologies bring benefit to focused screening campaigns in specific therapeutic areas as well as large scale screening operations."

Further Information:

Request Information From Vendor

Related Products

Genedata Collaboration Yields Hit to Lead Solution
The release Hit Profiler exploits semantic integration technologies to display screening results.

Genedata Unveils Computational Solution Genedata Expressionist®
Genedata Expressionist designed for rapid cross-omics data analysis.

Related news from our archive

Genedata Collaborates with HepatoSys Systems Biology Competence Network
Genedata has developed a computational system to analyze molecular processes in mammalian liver cells.

Genedata Collaborates with €12.6M European Cancer Research Consortium
Company will provide research informatics for the consortium’s efforts to improve cancer diagnosis and treatment.

Global Expansion of Genedata’s Screening Analysis Collaboration with Roche
The multi-year expansion of the collaboration will include all Roche high HTS facilities in North America and Europe.